COMMUNIQUÉS West-GlobeNewswire

Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
09/09/2026
Collaboration provides dedicated patient financing for Femasys fertility solutions, helping reduce financial barriers to care across OB/GYN practices and fertility centers ATLANTA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- [...]
ImPact Biotech Announces Completion of Treatment in Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC and Positive Regulatory Updates
09/09/2026
– Successful t reatment of 91 patients with consistent safety and efficacy results observed to date ; interim data to be presented at ESMO Congress in October 2026 – – W ritten feedback from FDA following pre-NDA [...]
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
09/09/2026
CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced the grant of an [...]
Traver Strategic Holdings Acquires Apprio and Launches Varetis, Inc.
09/09/2026
ATLANTA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Traver Strategic Holdings LLC today announced its acquisition of Apprio, Inc., and the launch of Varetis, Inc., which will build on Apprio’s decades of federal experience [...]
H1 Acquires Defacto Health to Strengthen Provider Network Intelligence
09/09/2026
Acquisition brings provider-network data and experienced healthcare data leaders to H1 NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- H1 , the AI-powered platform that connects the world to the right doctors, today [...]
Parity and Maine RMOMS Partnership Demonstrates New Approach to Strengthening Rural Maternity Care
09/09/2026
Work across three Maine hospitals identifies more than $1.1 million in potential annual nurse labor savings while supporting safe, patient-centered staffing and long-term maternity care sustainability PORTLAND, Maine, [...]
Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program
09/09/2026
New model demonstrates the clinical and economic value of medication persistence, companion program engagement, and projected disease risk reduction SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq [...]
John Patrick University Launches New Radiography Bridge Program to Help Address Growing Demand for Radiologic Technologists
09/09/2026
New pathway allows qualified Limited Scope Radiographers to apply up to 21 credits toward an Associate of Science degree and potentially complete the program in as little as 16 months SOUTH BEND, Ind., Sept. 09, 2026 ( [...]
AIM ImmunoTech Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video
09/09/2026
Company continues to advance Phase 2 DURIPANC study and broader clinical strategy evaluating Ampligen’s potential to reshape the tumor microenvironment and enhance checkpoint inhibition Access it here OCALA, Fla., Sept [...]
A Syngenta e a Amoéba concluíram um acordo de distribuição exclusivo na Europa para oferecer aos produtores de cereais uma inovação biofungicida
09/09/2026
Bâle (Suíça) e Chassieu (França), Sept. 09, 2026 (GLOBE NEWSWIRE) -- Este acordo exclusivo abrangerá o mercado de cereais na União Europeia, no Reino Unido, na Ucrânia e na Suíça, com os primeiros lançamentos comerciais [...]
Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
09/09/2026
SARASOTA, FLA., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), ”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a [...]
LifeStance Health Group Announces Pricing of Secondary Public Offering
09/09/2026
SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica réaffirme à l’unanimité sa confiance dans le management et la stratégie de l’entreprise
09/09/2026
Le Conseil d’administration d’EssilorLuxottica réaffirme à l’unanimité sa confiance dans le management et la stratégie de l’entreprise Paris, France (9 septembre 2026) – Faisant suite aux récentes informations parues [...]
EssilorLuxottica: EssilorLuxottica Board of Directors unanimously reaffirms confidence in the Company’s leadership and strategy
09/09/2026
EssilorLuxottica Board of Directors unanimously reaffirms confidence in the Company’s leadership and strategy Paris, France (9 September 2026) – With reference to recent press reports and public statements, the [...]
Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026
09/09/2026
Industry symposium to explore local delivery of combination antibiotics across spine and arthroplasty Poster showcases the efficacy of STIMULAN ® calcium sulfate beads, loaded with a combination of Gram-positive and [...]
ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
09/09/2026
Investment supports application of ViaNautis’ polyNaut ® platform to regenerative therapies for spinal cord injury, where targeted delivery remains a huge barrier Adds a new high-value CNS indication and provides [...]
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
09/09/2026
- Treatment with oral infigratinib for 52 weeks in PROPEL 3 resulted in favorable trends against placebo in clinically meaningful exploratory endpoints including sleep apnea and otitis media events Stabilization of [...]
Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
09/09/2026
Bâle (Suisse) et Chassieu (France) , 09 sept. 2026 (GLOBE NEWSWIRE) -- Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide Cet accord [...]
Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers
09/09/2026
Basel, Switzerland and Chassieu, France, , Sept. 09, 2026 (GLOBE NEWSWIRE) -- The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first [...]

Pages